Translational Research Advancing Therapies for Amyotrophic Lateral Sclerosis (ALS) Drug Discovery Contract - LOI

The ALS Association’s Translational Research Advancing Therapies for ALS (TREAT ALS™) program funds research from early target identification to preclinical research and early pilot clinical trials. As part of the program, The Association is requesting letters of intent for its drug development contract program, milestone driven research to develop new treatments for ALS. The program complements the Department of Defense ALS research program and the translational programs at the National Institutes of Health. Clinical trials will not be supported in this program. Funding: $500K over 2 years.
http://www.alsa.org/news/archive/treat-als.html